Skip to content
TrialScanner

NCT04927793

Absorption, Metabolism, and Excretion (AME) Study of [14C]EDP-938 in Healthy Male Subjects

Phase 1CompletedENTALead

Registry record

Lead sponsor
Enanta Pharmaceuticals, Inc
Conditions
Respiratory Syncytial Virus (RSV)
Primary completion
Jul 4, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04927793 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04927793: Absorption, Metabolism, and... | TrialScanner